Rory B. Riggs - 31 Dec 2021 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Issuer symbol
ITCI
Transactions as of
31 Dec 2021
Net transactions value
+$15,702
Form type
4
Filing time
04 Jan 2022, 20:50:58 UTC
Previous filing
30 Dec 2021
Next filing
18 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Award $15,702 +300 +0.39% $52.34 76,815 31 Dec 2021 Direct
holding ITCI Common Stock 226,670 31 Dec 2021 Held by New Ventures I, LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Riggs is Managing Member of New Ventures I, LLC and may be deemed to beneficially own the securities held by New Ventures I, LLC. Mr. Riggs disclaims beneficial ownership of the securities held by New Ventures I, LLC except to the extent of his pecuniary interest therein.